About this Research Topic
High-energy charged particles represent a cutting-edge technique in radiation oncology. Protons and carbon ions are used in several centers all over the world for the treatment of different solid tumors. Typical indications are ocular malignancies, tumors of the base of the skull, hepatocellular carcinomas and various sarcomas. The physical characteristics of the charged particles (Bragg peak) allow sparing of much more normal tissues than it is possible using conventional X-rays, and for this reason all pediatric tumors are considered eligible for protontherapy. Ions heavier than protons also display special radiobiological characteristics, which make them effective against radioresistant and hypoxic tumors.
On the other hand, protons and ions with high charge (Z) and energy (HZE particles) represent a major risk for human space exploration. The main late effect of radiation exposure is cancer induction, and at the moment the dose limits for astronauts are based on cancer mortality risk. The Mars Science Laboratory (MSL) measured the dose on the route to Mars and on the planet’s surface, suggesting that a human exploration missions will exceed the radiation risk limits. Notwithstanding many studies on carcinogenesis induced by protons and heavy ions, the risk uncertainty remains very high.
In this research topic we aim at gathering the experiences and opinions of scientists dealing with high-energy charged particles either for cancer treatment or for space radiation protection. Clinical results with protons and heavy ions, as well as ongoing and planned clinical trials will be described. In addition, ground-based and spaceflight studies on the effects of space radiation will be reported. Particularly relevant for space studies are the clinical results on normal tissue complications and second cancers.
Physics, biology, and medical contributions in this field are welcome. Physics manuscripts should focus on contributions of nuclear and medical physics to particle therapy, and measurements or calculations of the dose to normal tissues. They will also include mitigation strategies for spaceflight, such as passive and active shielding. Biology contributions should focus on charged particle carcinogenesis or cancer radiobiology with heavy ions. Medical studies will describe clinical outcomes in patients or impact on astronauts’ health.
On the other hand, protons and ions with high charge (Z) and energy (HZE particles) represent a major risk for human space exploration. The main late effect of radiation exposure is cancer induction, and at the moment the dose limits for astronauts are based on cancer mortality risk. The Mars Science Laboratory (MSL) measured the dose on the route to Mars and on the planet’s surface, suggesting that a human exploration missions will exceed the radiation risk limits. Notwithstanding many studies on carcinogenesis induced by protons and heavy ions, the risk uncertainty remains very high.
In this research topic we aim at gathering the experiences and opinions of scientists dealing with high-energy charged particles either for cancer treatment or for space radiation protection. Clinical results with protons and heavy ions, as well as ongoing and planned clinical trials will be described. In addition, ground-based and spaceflight studies on the effects of space radiation will be reported. Particularly relevant for space studies are the clinical results on normal tissue complications and second cancers.
Physics, biology, and medical contributions in this field are welcome. Physics manuscripts should focus on contributions of nuclear and medical physics to particle therapy, and measurements or calculations of the dose to normal tissues. They will also include mitigation strategies for spaceflight, such as passive and active shielding. Biology contributions should focus on charged particle carcinogenesis or cancer radiobiology with heavy ions. Medical studies will describe clinical outcomes in patients or impact on astronauts’ health.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
